Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PreFluCel 2009/2010 Safety and Immunogenicity
NCT01063088Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Feb 2010
- Primary completion
- Mar 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of inactivated influenza vaccine (vero cell-derived) in influenza, sponsored by Resilience Government Services. Started Feb 2010; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01063088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063088.